Centogene, Takeda extend diagnostic partnership [Seeking Alpha]
Centogene N.V. - Common Shares (CNTG)
Last centogene n.v. - common shares earnings: 12/5 06:28 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Per the terms, the German biotech will continue to provide its testing solutions to Takeda ( TAK ) for the early and rapid diagnosis of patients with LSDs such as Fabry disease, Gaucher disease, and Hunter syndrome. “Extending our longstanding partnership with Takeda highlights the continuing need to accelerate diagnoses for LSD patients globally and the ability of CENTOGENE to fulfill this vital service,” Centogene's ( CNTG ) commercial chief Ian Rentsch remarked. The announcement marks the latest renewal of a deal CNTG first established in 2015 with Shire Pharmaceuticals, which the Japanese pharma giant acquired for $62B in 2019. Recommended For You More Trending News Recommended For You More Trending News Related Stocks In The News Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
CNTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNTG alerts
High impacting Centogene N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
CNTG
News
- CENTOGENE Receives Nasdaq Non-Compliance Notice [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Receives Nasdaq Non-Compliance NoticeGlobeNewswire
- Reproductive Genetics Market Analysis Report 2024-2032, Featuring Bangkok Genomics Innovation, Centogene, Fulgent Genetics, Igenomix, Invitae, PerkinElmer and Thermo Fisher Scientific [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersGlobeNewswire
- Surge in Adoption of Accurate Disease Diagnosis in Clinical Diagnostics Harnessing Growth of Multiomic Market [Yahoo! Finance]Yahoo! Finance
CNTG
Sec Filings
- 4/2/24 - Form 6-K
- 3/19/24 - Form 6-K
- 2/29/24 - Form 6-K
- CNTG's page on the SEC website